Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 14 of 79

  1. The predictive biomarkers of immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) still need to be further explored. This study aims to establish a new immune prognosis biomarker to predict th...

    Authors: Rujia Zhang, Haoran Zhao, Peng Wang, Zuoming Guo, Chunxun Liu and Zhaowei Qu
    Citation: BMC Cancer 2023 23:1181
    Content type: Research Published on:

  3. m6A is the most prevalent and abundant form of mRNA modifications and is closely related to tumor proliferation, differentiation, and tumorigenesis. In this study, we try to conduct an effective prediction mod...

    Authors: Lianzi Wang, Shubing Zhang, Huimin Li, Yang Xu, Qiang Wu, Jilong Shen, Tao Li and Yuanhong Xu
    Citation: BMC Cancer 2021 21:876
    Content type: Research Published on:

  4. Cancer patient pathways (CPPs) were implemented in Norway to reduce unnecessary waiting times, regional variations, and to increase the predictability of cancer care for the patients. This study aimed to deter...

    Authors: Yngvar Nilssen, Odd Terje Brustugun, Morten Tandberg Eriksen, Marianne G. Guren, Erik Skaaheim Haug, Bjørn Naume, Ellen Schlichting and Bjørn Møller
    Citation: BMC Cancer 2022 22:220
    Content type: Research Published on:

  5. The coronavirus disease 2019 (COVID-19) pandemic has rapidly and dramatically influenced healthcare across Japan. However, the influence of the COVID-19 pandemic on the number of newly diagnosed cancer, surgic...

    Authors: Takeshi Terashima, Hiroshi Konishi, Yasunori Sato, Muneki Igarashi, Takafumi Yanagibashi, Ryo Konno, Hideyuki Saya, Yuichiro Doki and Tadao Kakizoe
    Citation: BMC Cancer 2022 22:1303
    Content type: Research Published on:

  6. Recent studies have indicated the possible function of miR-217 in tumorigenesis. However, the roles of miR-217 in colorectal cancer (CRC) are still largely unknown.

    Authors: Bo Wang, Zhan-long Shen, Ke-wei Jiang, Gang Zhao, Chun-you Wang, Yi-chao Yan, Yang Yang, Ji-zhun Zhang, Chao Shen, Zhi-dong Gao, Ying-jiang Ye and Shan Wang
    Citation: BMC Cancer 2015 15:437
    Content type: Research article Published on:

  9. The association involving mismatch repair (MMR) genes, molecular subtype and specific immune cell group in tumor microenvironment has been focused by more recent studies. Its prognosis value in lung adenocarci...

    Authors: Liangliang Cai, Hujia Hua, Xingyu Jiang, Xintian Xu, Hua Bai, Li Qian and Jianchun Duan
    Citation: BMC Cancer 2023 23:514
    Content type: Research Published on:

  11. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) recommended for the patients with subsolid nodule in early lung cancer stage is not routinely. The clinical value and impact in patients ...

    Authors: Mei Xie, Jie Gao, Xidong Ma, Jialin Song, Chongchong Wu, Yangyu Zhou, Tianjiao Jiang, Yiran Liang, Chen Yang, Xinyu Bao, Xin Zhang, Jie Yao, Ying Jing, Jianlin Wu, Jianxin Wang and Xinying Xue
    Citation: BMC Cancer 2024 24:372
    Content type: Research Published on:

  12. Adenosquamous carcinoma (ASC) is an uncommon histological subtype of lung cancer. The purpose of this study was to assess the cumulative incidences of lung cancer-specific mortality (LC-SM) and other cause-spe...

    Authors: Xiao Wu, Wenfeng Yu, R. H. Petersen, Hongxu Sheng, Yiqing Wang, Wang Lv and Jian Hu
    Citation: BMC Cancer 2020 20:429
    Content type: Research article Published on:

  13. Tyrosine kinase inhibitors (TKIs) are mainstays of cancer treatment. However, their clinical benefits are often constrained by acquired resistance. To overcome such outcomes, we have rationally engineered APG-...

    Authors: Douglas D. Fang, Ran Tao, Guangfeng Wang, Yuanbao Li, Kaixiang Zhang, Chunhua Xu, Guoqin Zhai, Qixin Wang, Jingwen Wang, Chunyang Tang, Ping Min, Dengkun Xiong, Jianyong Chen, Shaomeng Wang, Dajun Yang and Yifan Zhai
    Citation: BMC Cancer 2022 22:752
    Content type: Research Published on:

  14. Oral squamous cell carcinoma (OSCC) is the dominant histologic type of oral cancer. Locally advanced OSCC remains a major therapeutic challenge. Our study aimed to develop and validate nomograms predicting sur...

    Authors: Zhiliang Nie, Pengcheng Zhao, Yishan Shang and Bo Sun
    Citation: BMC Cancer 2021 21:372
    Content type: Research article Published on:

  15. Autophagy is a programmed cell degradation mechanism that has been associated with several physiological and pathophysiological processes, including malignancy. Improper induction of autophagy has been propose...

    Authors: Xingxing Huo, Jian Qi, Kaiquan Huang, Su Bu, Wei Yao, Ying Chen and Jinfu Nie
    Citation: BMC Cancer 2020 20:771
    Content type: Research article Published on:

  18. STAT1 has been attributed a function as tumor suppressor. However, in breast cancer data from microarray analysis indicated a predictive value of high mRNA expression levels of STAT1 and STAT1 target genes bel...

    Authors: Piotr Tymoszuk, Pornpimol Charoentong, Hubert Hackl, Rita Spilka, Elisabeth Müller-Holzner, Zlatko Trajanoski, Peter Obrist, Françoise Revillion, Jean-Philippe Peyrat, Heidi Fiegl and Wolfgang Doppler
    Citation: BMC Cancer 2014 14:257
    Content type: Research article Published on:

  19. The role of surgery for the primary tumor in breast cancer patients with bone metastases (BM) remains unclear. The purpose of this study was to determine the impact of surgery for the primary tumor in breast c...

    Authors: Zhangheng Huang, Xin Zhou, Yuexin Tong, Lujian Zhu, Ruhan Zhao and Xiaohui Huang
    Citation: BMC Cancer 2021 21:222
    Content type: Research article Published on:

  20. CXCL1 is a chemotactic cytokine shown to regulate breast cancer progression and chemo-resistance. However, the prognostic significance of CXCL1 expression in breast cancer has not been fully characterized. Fib...

    Authors: An Zou, Diana Lambert, Henry Yeh, Ken Yasukawa, Fariba Behbod, Fang Fan and Nikki Cheng
    Citation: BMC Cancer 2014 14:781
    Content type: Research article Published on:

  23. Gefitinib, an EGFR-tyrosine kinase inhibitor, significantly improve prognosis in patients with advanced non-small cell lung cancer (NSCLC). The aim of this study was to evaluate the usefulness of MUC1 and vasc...

    Authors: Jian Li, Yi-Ming Hu, Yong-Jie Du, Li-Rong Zhu, Hai Qian, Yan Wu and Wei-Lin Shi
    Citation: BMC Cancer 2014 14:848
    Content type: Research article Published on:

  24. To reduce disease recurrence after radical surgery for lung squamous cell carcinomas (SQCCs), accurate prediction of recurrent high-risk patients is required for efficient patient selection for adjuvant chemot...

    Authors: Yusuke Takanashi, Kazuhito Funai, Fumihiro Eto, Kiyomichi Mizuno, Akikazu Kawase, Hong Tao, Takuya Kitamoto, Yutaka Takahashi, Haruhiko Sugimura, Mitsutoshi Setou, Tomoaki Kahyo and Norihiko Shiiya
    Citation: BMC Cancer 2021 21:1232
    Content type: Research article Published on:

  25. To explore the correlation of flash dual source computed tomography perfusion imaging (CTPI) and regional lymph node metastasis of non-small cell lung cancer (NSCLC), and to evaluate the value of CT perfusion ...

    Authors: Tingting Huang, Hui Sun, Xianli Luo, Xuemei Zhang, Kaiyuan Jin, Feng Wang, Lv Sun, Nianlan Cheng, Shuo Wu, Qin Lou and Bangguo Li
    Citation: BMC Cancer 2020 20:547
    Content type: Research article Published on:

  26. NQO1 (NAD(P)H: quinone oxidoreductase-1), located on chromosome 16q22, functions primarily to protect normal cells from oxidant stress and electrophilic attack. Recent studies have revealed that NQO1 is expres...

    Authors: Yue Ma, Jienan Kong, Guanghai Yan, Xiangshan Ren, Dan Jin, Tiefeng Jin, Lijuan Lin and Zhenhua Lin
    Citation: BMC Cancer 2014 14:414
    Content type: Research article Published on:

  27. NAD(P)H:quinone oxidoreductase (NQO1) is a flavoprotein that catalyzes two-electron reduction and detoxification of quinones and its derivatives. NQO1 catalyzes reactions that have a protective effect against ...

    Authors: Xuelian Cui, Lianhua Li, Guanghai Yan, Kai Meng, Zhenhua Lin, Yunze Nan, Guang Jin and Chunyu Li
    Citation: BMC Cancer 2015 15:244
    Content type: Research article Published on:

  28. Ovarian clear cell carcinoma (OCCC) is a special pathological type of epithelial ovarian carcinoma (EOC). We conducted this research to investigate the clinical characteristics and outcomes of OCCC and to prov...

    Authors: Chenchen Zhu, Jing Zhu, Lili Qian, Hanyuan Liu, Zhen Shen, Dabao Wu, Weidong Zhao, Weihua Xiao and Ying Zhou
    Citation: BMC Cancer 2021 21:322
    Content type: Research article Published on:

  29. Even today, treatment of Stage III NSCLC still poses a serious challenge. So far, surgical resection is the treatment of choice. Patients whose tumour is not resectable or who are unfit to undergo surgery are ...

    Authors: AD Jensen, MW Münter, H Bischoff, R Haselmann, C Timke, R Krempien, F Sterzing, S Nill, S Heeger, A Hoess, U Haberkorn, PE Huber, M Steins, M Thomas, J Debus and KK Herfarth
    Citation: BMC Cancer 2006 6:122
    Content type: Study protocol Published on:

  30. Dihydropyrimidinase-like 3 (DPYSL3) is a cytosolic phosphoprotein expressed in the nervous system and is crucial for neurogenesis. A previous study showed that increased DPYSL3 expression promotes tumour aggre...

    Authors: Peir-In Liang, Hong-Yue Lai, Ti-Chun Chan, Wei-Ming Li, Chung-Hsi Hsing, Steven K. Huang, Kun-Lin Hsieh, Wen-Hsin Tseng, Tzu-Ju Chen, Wan-Shan Li, Huan-Da Chen, Yu-Hsuan Kuo and Chien-Feng Li
    Citation: BMC Cancer 2023 23:599
    Content type: Research Published on:

  32. This study aimed to evaluate the efficacy and side effects of first-line afatinib treatment in a real-world setting in Vietnam.

    Authors: Cam Phuong Pham, Thi Thai Hoa Nguyen, Anh Tu Do, Tuan Khoi Nguyen, Thi Anh Thu Hoang, Tuan Anh Le, Dinh Thy Hao Vuong, Dac Nhan Tam Nguyen, Van Khiem Dang, Thi Oanh Nguyen, Van Luan Pham, Minh Hai Nguyen, Thi Huyen Trang Vo, Hung Kien Do, Ha Thanh Vu, Thi Thuy Hang Nguyen…
    Citation: BMC Cancer 2024 24:176
    Content type: Research Published on:

  33. BRCA1 (B), ERCC1 (E), RRM1 (R) and TYMS (T) mRNA expression has been extensively studied with respect to NSCLC patient outcome upon various chemotherapy agents. However, these markers have not been introduced ...

    Authors: Vassiliki Kotoula, Dimitrios Krikelis, Vasilios Karavasilis, Triantafillia Koletsa, Anastasia G Eleftheraki, Despina Televantou, Christos Christodoulou, Stefanos Dimoudis, Ippokratis Korantzis, Dimitrios Pectasides, Konstantinos N Syrigos, Paris A Kosmidis and George Fountzilas
    Citation: BMC Cancer 2012 12:342
    Content type: Research article Published on:

  34. Lung adenocarcinoma (LUAD) remains a crucial factor endangering human health. Gene-based clinical predictions could be of great help for cancer intervention strategies. Here, we tried to build a gene-based sur...

    Authors: Yanlu Xiong, Jie Lei, Jinbo Zhao, Qiang Lu, Yangbo Feng, Tianyun Qiao, Shaowei Xin, Yong Han and Tao Jiang
    Citation: BMC Cancer 2020 20:1046
    Content type: Research article Published on:

  36. Despite major advances in cancer therapeutics, the therapeutic options of Lung Squamous Cell Carcinoma (LSCC)-specific remain limited. Furthermore, the current staging system is imperfect for defining a progno...

    Authors: Chen-ye Shao, Jing Luo, Sheng Ju, Chu-ling Li, Cheng Ding, Jun Chen, Xiao-long Liu, Jun Zhao and Li-qin Yang
    Citation: BMC Cancer 2023 23:920
    Content type: Research Published on:

  37. Perineural invasion (PNI) is the invasion of nerves by cancer cells and is associated with poor survival in stage II colorectal cancer. However, PNI can be further subdivided according to the depth of invasion...

    Authors: Hao Chen, Chao Wang, Zexian Chen, Tianze Huang, Yanyun Lin, Junguo Chen, Bin Zhang and Xiaosheng He
    Citation: BMC Cancer 2024 24:433
    Content type: Research Published on:

  38. Central nervous system (CNS) brain metastasis of advanced non-small cell lung cancer (NSCLC) patients confers a worse quality of life and prognosis. The efficacy comparison of two first-generation epidermal gr...

    Authors: Meng-Xia Li, Hao He, Zhi-Hua Ruan, Yu-Xi Zhu, Rong-Qing Li, Xiao He, Bao-Hua Lan, Zhi-Min Zhang, Guo-Dong Liu, Hua-Liang Xiao, Yan Wu, Bo Zhu, Ge Wang and Zhen-Zhou Yang
    Citation: BMC Cancer 2017 17:245
    Content type: Research article Published on:

  39. Chemotherapeutics can stimulate immune antitumor response by inducing immunogenic cell death (ICD), which is activated by Damage-Associated Molecular Patterns (DAMPs) like the exposure of calreticulin (CRT) on...

    Authors: José Ignácio Gonzalez Solari, Eduardo Filippi-Chiela, Emily Salles Pilar, Vitória Nunes, Esteban Alberto Gonzalez, Fabrício Figueiró, Cristiano Feijó Andrade and Fábio Klamt
    Citation: BMC Cancer 2020 20:474
    Content type: Research article Published on:

  40. The combination of immune-checkpoint inhibitors with chemotherapy has become the standard of treatment for non-small cell lung cancer (NSCLC) patients. However, the association between therapeutic efficacy and...

    Authors: Kana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada, Yuta Kawakami, Keita Miura, Taichi Miyawaki, Tetsuhiko Asao, Ryo Ko, Takehito Shukuya, Rina Shibayama, Shuko Nojiri and Kazuhisa Takahashi
    Citation: BMC Cancer 2022 22:1047
    Content type: Research Published on:

  41. Brain-derived neurotrophic factor (BDNF) has been reported to promote tumorigenesis and progression in several human malignancies. The purpose of this study was to explore the function of BDNF in lung squamous...

    Authors: Si-yang Zhang, Lin-ping Hui, Chun-yan Li, Jian Gao, Ze-shi Cui and Xue-shan Qiu
    Citation: BMC Cancer 2016 16:171
    Content type: Research article Published on:

  42. High medication literacy is the basis of rational medication application and is essential for the management of severe adverse drug reactions. The objective of the present study was to assess the level of medi...

    Authors: Ruofei Du, Huashan Yang, Huiyue Zhou, Lixia Ma, Mikiyas Amare Getu, Changying Chen and Tao Wang
    Citation: BMC Cancer 2022 22:491
    Content type: Research Published on:

  43. Runt-related transcription factor 1 (RUNX1) is a vital regulator of mammalian expression. Despite multiple pieces of evidence indicating that dysregulation of RUNX1 is a common phenomenon in human cancers, the...

    Authors: Zhouting Tuo, Ying Zhang, Xin Wang, Shuxin Dai, Kun Liu, Dian Xia, Jinyou Wang and Liangkuan Bi
    Citation: BMC Cancer 2022 22:523
    Content type: Research Published on:

  44. Nucleolar and spindle-associated protein 1 (NUSAP1) was shown to be involved in cell cycle regulation in cancer. However, its prognostic value and underlying mechanism in ovarian cancer remain unclear.

    Authors: Rui Gou, Mingjun Zheng, Yuexin Hu, Lingling Gao, Shuang Wang, Ouxuan Liu, Xiao Li, Liancheng Zhu, Juanjuan Liu and Bei Lin
    Citation: BMC Cancer 2022 22:690
    Content type: Research article Published on:

  45. Venous thromboembolism (VTE) and cancer are strongly associated. In France, evidence on patients with pancreatic, upper GI [gastrointestinal], lower GI, lung, or breast cancer-associated VTE and their hospital...

    Authors: F. Couturaud, I. Mahé, J. Schmidt, J-C. Gleize, T. Lafon, A. Saighi, F. Sedjelmaci, L. Bertoletti and P. Mismetti
    Citation: BMC Cancer 2023 23:531
    Content type: Research Published on:

  46. The efficacy of prophylactic cranial irradiation (PCI) in treating patients with small cell lung cancer (SCLC) has not been clear, and recent randomized studies have demonstrated conflicting results from previ...

    Authors: Xin Yin, Danfang Yan, Miao Qiu, Liming Huang and Sen-Xiang Yan
    Citation: BMC Cancer 2019 19:95
    Content type: Research article Published on:

  47. Dacomitinib is a second-generation, irreversible epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). ARCHER-1050 showed that this agent can improve progression-free survival and overall surv...

    Authors: Bo Zhang, Chunlei Shi, Zhiqiang Gao, Hua Zhong, Liwen Xiong, Aiqin Gu, Weimin Wang, Tianqing Chu, Wei Zhang, Huimin Wang, Xueyan Zhang, Runbo Zhong and Baohui Han
    Citation: BMC Cancer 2022 22:294
    Content type: Study protocol Published on:

  48. Lung adenocarcinoma (LAC) is composed of lepidic, papillary, mucinous, micropapillary and solid components in its parenchyma. Complex responses to therapeutics result from intratumoral heterogeneity. However, ...

    Authors: Yiran Cai, Hongbo Wu, Xiaoqin Shi, Yujie Dong, Xiujun Chang, Li Zhang, Lijuan Zhou, Dan Su and Ming Yang
    Citation: BMC Cancer 2020 20:148
    Content type: Research article Published on:

  49. To improve the efficacy of first-line therapy for advanced non-small cell lung cancer (NSCLC), additional maintenance chemotherapy may be given after initial induction chemotherapy in patients who did not prog...

    Authors: Luis G Paz-Ares, Sedat Altug, Alexandra Thareau Vaury, Jesús Corral Jaime, Francesca Russo and Carla Visseren-Grul
    Citation: BMC Cancer 2010 10:85
    Content type: Study protocol Published on:

  50. Neoadjuvant chemotherapy is effective in improving survival of resectable NSCLC. Based on findings in the adjuvant and metastatic setting, FDG positron emission tomography (PET) scans may offer early prognosti...

    Authors: Perrin E. Romine, Renato G. Martins, Keith D. Eaton, Douglas E. Wood, Fatemeh Behnia, Bernardo H. L. Goulart, Michael S. Mulligan, Sarah G. Wallace, Elizabeth Kell, Julie E. Bauman, Shilpen A. Patel and Hubert J. Vesselle
    Citation: BMC Cancer 2019 19:70
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us